Skip to main content

Diagnostic options · UAE

Genetic Disorders tests in Dubai & UAE

Compare available Genetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

136

Listed price range

1,100.00–4,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Disorders test prices

Showing 1–15 of 136 matching tests.

Genetic Disorders diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-4798
AARS2 Gene Leukoencephalopathy with Ovarian Failure Genetic Test

This genetic test identifies pathogenic variants in the AARS2 gene associated with progressive leukoencephalopathy and ovarian failure.

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AARS2 gene"]
Parameters
[]
Preparation
["No fasting required", "Ensure hydration", "Disclose all current medications"]
Indications
["Suspected AARS2-related leukoencephalopathy", "Ovarian insufficiency with neurological symptoms", "Family planning in affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81323-7 ICD-10: G93.8
Clinical summary
This genetic test identifies pathogenic variants in the AARS2 gene associated with progressive leukoencephalopathy and ovarian failure.
TEST-3735
ABCD1 Gene Sequencing for Adrenoleukodystrophy & Adrenomyeloneuropathy (NGS) Test

This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD) and adrenomyeloneuropathy (AMN). It provides definitive molecu...

Peripheral Whole Blood (EDTA) 21–28 Days (3–4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCD1 gene", "Copy Number Variants (CNVs) in ABCD1"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medication use"]
Indications
["Confirmation of suspected X-ALD/AMN", "Identification of asymptomatic carriers", "Genetic counseling for affected families", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 64579-6 ICD-10: E71.520
Clinical summary
This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD) and adrenomyeloneuropathy (AMN). It provides definitive molecular confirmation, identifies carriers, and informs treatment decisions.
TEST-3528
ACE Gene Renal Tubular Dysgenesis Genetic Test

This genetic test identifies mutations in the ACE gene associated with autosomal recessive renal tubular dysgenesis.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACE gene", "Autosomal recessive inheritance patterns"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant family history"]
Indications
["Family history of unexplained neonatal renal failure", "Suspected autosomal recessive renal tubular dysgenesis", "Carrier screening in families with affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q61.4
Clinical summary
This genetic test identifies mutations in the ACE gene associated with autosomal recessive renal tubular dysgenesis.
TEST-4000
ADA2 Gene (CECR1) Genetic Testing for DADA2 & Sneddon Syndrome Test

This test evaluates the entire ADA2 gene for pathogenic variants associated with Deficiency of Adenosine Deaminase 2 (DADA2) and related conditions like Sneddon syndrome.

Whole Blood (Peripheral) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ADA2 gene", "Gene coverage of all exons, intron/exon boundaries, and promoter region"]
Parameters
[]
Preparation
["No fasting required", "No special preparation needed", "Mandatory pre-test genetic counseling is required"]
Indications
["Suspected DADA2 based on clinical presentation", "Family history of DADA2", "Differential diagnosis of autoinflammatory vasculitis", "Evaluation of Sneddon syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92879-2 ICD-10: E79.8
Clinical summary
This test evaluates the entire ADA2 gene for pathogenic variants associated with Deficiency of Adenosine Deaminase 2 (DADA2) and related conditions like Sneddon syndrome.
TEST-3728
ADAR Gene Aicardi-Goutières Syndrome Type 6 Genetic Test

This genetic test identifies pathogenic variants within the ADAR gene, confirming the diagnosis of Aicardi-Goutières syndrome type 6.

Peripheral whole blood (2 mL EDTA) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ADAR gene sequence", "Pathogenic variants in ADAR gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected Aicardi-Goutières syndrome type 6", "Elevated CSF interferon-alpha", "Negative TORCH screen", "Family history of Aicardi-Goutières syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82299-8 ICD-10: G93.41
Clinical summary
This genetic test identifies pathogenic variants within the ADAR gene, confirming the diagnosis of Aicardi-Goutières syndrome type 6.
TEST-6077
Alpha-2-Macroglobulin Deficiency Genetic Test (A2M NGS)

This test identifies genetic variants in the A2M gene associated with alpha-2-macroglobulin deficiency.

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["A2M gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["No dietary restrictions", "No medication adjustments"]
Indications
["Suspected alpha-2-macroglobulin deficiency", "Family history of alpha-2-macroglobulin deficiency", "Evaluation of metabolic disorders", "Evaluation of pulmonary conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 91854-7 ICD-10: E88.09
Clinical summary
This test identifies genetic variants in the A2M gene associated with alpha-2-macroglobulin deficiency.
TEST-6035
AMACR Gene (Bile Acid Synthesis Defect Type 4, Congenital) Genetic Test

This test analyzes the AMACR gene for pathogenic variants associated with congenital bile acid synthesis defect type 4.

Whole Blood (Peripheral) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the AMACR gene", "Single nucleotide variants", "Indels", "Copy number changes"]
Parameters
[]
Preparation
[]
Indications
["Suspected congenital bile acid synthesis defect type 4", "Family screening", "Reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 47956-1 ICD-10: E71.5
Clinical summary
This test analyzes the AMACR gene for pathogenic variants associated with congenital bile acid synthesis defect type 4.
TEST-5453
AMELX Gene Sequencing Test (Amelogenesis Imperfecta, Type 1E)

This test evaluates the AMELX gene for mutations associated with X-linked Amelogenesis Imperfecta Type 1E.

Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants in AMELX gene", "Small indels in AMELX gene", "Copy Number Variations (CNV) in AMELX gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Clinical signs of Amelogenesis Imperfecta", "Family history suggestive of X-linked inheritance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81353-1 ICD-10: K00.4
Clinical summary
This test evaluates the AMELX gene for mutations associated with X-linked Amelogenesis Imperfecta Type 1E.
TEST-259
Angelman Syndrome Genetic Test

This test evaluates DNA methylation patterns at the 15q11-q13 locus to diagnose Angelman syndrome.

EDTA whole blood 12 Working Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["DNA methylation patterns", "15q11-q13 imprinting center defects", "Maternal deletion of chromosome 15q11-q13", "Paternal uniparental disomy"]
Parameters
[]
Preparation
["No fasting required", "Maintain current medication regimen unless advised otherwise by a physician"]
Indications
["Clinical suspicion of Angelman syndrome based on characteristic features", "Developmental delay or intellectual disability of unknown cause", "Family history of Angelman syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21774-8 ICD-10: Q93.51
Clinical summary
This test evaluates DNA methylation patterns at the 15q11-q13 locus to diagnose Angelman syndrome.
TEST-5505
ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test

This test identifies pathogenic variants in the ARMC4 gene associated with primary ciliary dyskinesia type 23 (PCD23).

Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ARMC4 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of current medications"]
Indications
["Suspected primary ciliary dyskinesia", "Family history of PCD", "Recurrent respiratory infections", "Infertility evaluation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-5 ICD-10: Q34.8
Clinical summary
This test identifies pathogenic variants in the ARMC4 gene associated with primary ciliary dyskinesia type 23 (PCD23).
TEST-2359
ATR Gene Seckel Syndrome Type 1 Next-Generation Sequencing (Genetic Test

This genetic test identifies pathogenic variants in the ATR gene associated with Seckel syndrome type 1.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic single nucleotide variants (SNVs)", "Small insertions or deletions (indels)", "Exon-level copy number changes (CNVs)"]
Parameters
[]
Preparation
["No special preparation such as fasting is required.", "Stay well hydrated before collection."]
Indications
["Suspected Seckel syndrome type 1", "Family history of Seckel syndrome type 1", "Need for definitive molecular diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81267-6 ICD-10: Q87.1
Clinical summary
This genetic test identifies pathogenic variants in the ATR gene associated with Seckel syndrome type 1.
TEST-5185
B4GALT7 Gene Ehlers-Danlos Syndrome Progeroid Type 1 Genetic Test

This genetic test identifies pathogenic variants in the B4GALT7 gene associated with Ehlers-Danlos syndrome progeroid type 1.

Whole Blood (EDTA, 2–5 mL) or FTA Card 21–28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the B4GALT7 gene", "Point mutations", "Small insertions/deletions", "Large rearrangements"]
Parameters
[]
Preparation
["No fasting required", "Inform clinical team of known bleeding disorder or INR > 3.0", "Genetic counseling session advised prior to testing"]
Indications
["Suspected Ehlers-Danlos syndrome progeroid type 1", "Family history of connective tissue disorders", "Definitive diagnosis", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-7 ICD-10: Q79.6
Clinical summary
This genetic test identifies pathogenic variants in the B4GALT7 gene associated with Ehlers-Danlos syndrome progeroid type 1.
TEST-3961
BBS10 Gene Bardet‑Biedl Syndrome Type 10 Genetic Test

This genetic test identifies pathogenic variants within the BBS10 gene, which are associated with Bardet-Biedl syndrome type 10.

Peripheral Whole Blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the BBS10 gene", "Copy number variants in the BBS10 gene"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Suspected Bardet-Biedl syndrome type 10", "Family history of Bardet-Biedl syndrome", "Clinical features suggestive of ciliopathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92766-8 ICD-10: Q87.8
Clinical summary
This genetic test identifies pathogenic variants within the BBS10 gene, which are associated with Bardet-Biedl syndrome type 10.
TEST-2472
BMP4 Gene Genetic Test (Orofacial Cleft Type 11)

This diagnostic test evaluates the BMP4 gene for pathogenic variants associated with nonsyndromic orofacial cleft type 11.

Peripheral whole blood (EDTA) or buccal swab / FTA card 3–4 weeks (12–16 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the BMP4 gene", "Full coding region and splice sites coverage"]
Parameters
[]
Preparation
["No fasting required", "Inform doctor of all prescribed drugs"]
Indications
["Diagnosis of nonsyndromic orofacial cleft type 11", "Familial risk assessment", "Tailored surgical planning", "Prenatal testing guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98527-6 ICD-10: Q37.9
Clinical summary
This diagnostic test evaluates the BMP4 gene for pathogenic variants associated with nonsyndromic orofacial cleft type 11.
TEST-5411
BRAT1 Gene Neurodevelopmental Disorder with Cerebellar Atrophy and with or without Seizures Genetic Test

This test identifies pathogenic variants in the BRAT1 gene, associated with a rare neurodevelopmental syndrome.

Whole Blood (3–5 mL EDTA), Extracted DNA (min 2 µg), or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["BRAT1 gene sequence", "Pathogenic variants in BRAT1 gene"]
Parameters
[]
Preparation
["Provide a detailed referral letter from a neurologist", "Mandatory pre-test genetic counselling session"]
Indications
["Unexplained global developmental delay", "Brain MRI revealing cerebellar atrophy", "Suspected BRAT1-related syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77186-9 ICD-10: G93.89, G40.909, Q04.8
Clinical summary
This test identifies pathogenic variants in the BRAT1 gene, associated with a rare neurodevelopmental syndrome.

Category overview

Genetic Disorders: overview

Understanding your family's risk for specific hereditary conditions empowers you to make proactive, highly informed health and reproductive decisions. As a core pillar of our advanced Genetics department, comprehensive testing for Genetic Disorders evaluates your DNA for a curated selection of mutations known to cause distinct, multi-system hereditary conditions. Utilizing state-of-the-art sequencing technology, this empowering molecular screening provides the critical clarity needed to assess carrier status and diagnostic risks, safely guiding informed family planning, proactive medical interventions, and specialized reproductive counseling. Widely respected for compassionate diagnostic excellence among premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, uncompromising analytical accuracy, and rapid, dependable reporting. Safeguard your family’s future—book your genetic disorders testing in UAE, arrange a comfortable clinic or home sample collection, or connect with our specialized medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.